February 13, 2025

Abdi İbrahim Partners with Japan’s Rohto for Innovative Eye Care Products

A Visionary Collaboration of Giants Begins

Abdi İbrahim, the leader of the Turkish pharmaceutical industry for 23 consecutive years, has entered into a strategic partnership with Rohto Pharmaceutical Co., Ltd., one of Japan’s most prominent pharmaceutical companies. As part of this collaboration, we reintroduced Rohto's innovative eye health product to patients in Türkiye with the assurance of Abdi İbrahim as of February 2025.

Guided by a mission to improve life and the future, Abdi İbrahim has been a pioneer in the pharmaceutical industry for 113 years, continually expanding its strong portfolio of international partnerships. Through this agreement with Rohto, a global leader in over-the-counter (OTC) medications, Abdi İbrahim will introduce a groundbreaking eye drop product, ROHTO DRY AID in February 2025. This product, developed using TEARSHIELD TECHNOLOGY to restore the natural tear film, sets itself apart from conventional eye drops, offering an innovative and advanced approach to eye health.

Süha Taşpolatoğlu, CEO of Abdi İbrahim, commented: “At Abdi İbrahim, we have upheld our leadership in Türkiye’s pharmaceutical sector for 113 years, rooted in our proud heritage. This leadership transcends national borders, reflecting our vision of fostering innovative and exemplary partnerships on a global scale. Our collaboration with Rohto is profoundly significant, uniting the missions of two well-established companies dedicated to enhancing human and societal well-being. Rohto’s 126-year legacy of innovation and advanced technological expertise, combined with Abdi İbrahim’s steadfast commitment to leadership, will enable us to deliver the advanced and innovative solutions in eye care to Turkish consumers.

Eye health and consumer health have been among our strategic focus areas in recent years, and this partnership is a testament to our vision in these fields. Furthermore, we believe this collaboration is a pivotal step toward elevating international standards within the Turkish pharmaceutical industry. By delivering innovative solutions to the Turkish market, this partnership will also strengthen Abdi İbrahim’s competitive edge on the global stage. Following our strategic partnership with Japan’s Otsuka in 2012, this new collaboration with another distinguished Japanese company represents another important milestone in deepening the commercial and cultural ties between our two nations.”

Rohto Representative’s Statement
Koji Suzuki, Manager of International Business Promotion Division commented as follows; At Rohto Pharmaceutical, we are honored to embark on this strategic partnership with Abdi İbrahim, a leader in Türkiye’s pharmaceutical industry with an impressive legacy. This collaboration marks a significant step forward in our shared mission of enhancing global health and well-being.

With over 100 years of innovation in Rohto’s eye care and Abdi İbrahim’s unparalleled network and expertise, we aim to deliver high-quality solutions to consumers in Türkiye. Rohto’s eye drops, developed through years of dedicated research, feature effective formulations, a smooth and pleasant user experience, and highly functional packaging. And among many of our products, ROHTO DRY AID represents the integration of our technology. These unique qualities allow us to bring enhanced value to the market and better meet the evolving needs of consumers.

Türkiye and Japan celebrated the 100th anniversary of the establishment of diplomatic relations in 2024. As entering a new century, we are pleased to contribute to further deepening commercial and cultural ties between our two countries.

Rohto: A Story of Inspiration
This year marks the 126th anniversary of Rohto Pharmaceutical Co., Ltd., a company that exemplifies a rich history and a forward-thinking vision. Founded in 1899 in the OTC category, Rohto has evolved into a global leader in eye care, dermatology, skincare, and advanced regenerative medicine.
Rohto Pharmaceutical has maintained its market leadership in OTC eye drops in Japan for 28 consecutive years*.
The company’s new slogan, “Moving the Heart,” reflects a vision that extends beyond products to touch lives, promoting health and happiness. Rohto’s 2030 vision, “Connect for Well-being,” embraces the goal of fostering better living for all through health, enhancing physical, mental, social, and environmental well-being, and striving to bring smiles to people everywhere.

*Remarks: Rohto is No.1 Eye Drop company in Japan based on INTAGE SDI, SRI+ unit sales of 28 continuous years from Jan. 1st, 1997 to Dec. 31st, 2024.